In episode 49 of Hims House, Jonathan Stern and Patrick Lester (Bayside) host Mark Mikhael and Joshua Fritzler from Olympia Pharmacy. Mark (CEO of Olympia), and Josh (CFO) discuss the evolution of their Orlando-based compounding pharmacy -- around GLP-1s and beyond. They dive into regulatory uncertainties, the impact of ongoing MFN negotiations involving Big Pharma, the role of compounded GLP-1s, and the burgeoning field of peptides. The conversation also touches on the concept of longevity through peptides and diagnostic testing, the broader implications of their work, and the role of Hims & Hers in the compounding industry.

(00:48) Olympia Pharmacy

(04:03) GLP-1s

(10:10) MFN negotiations

(20:45) Self-injection

(24:20) MAHA PAC appointment and goals

(31:43) Peptides peptides peptides

(42:32) Longevity & diagnostic testing

(45:56) Hims industry impact

Get full access to Hims House at himshouse.substack.com/subscribe